Silvia M Vidal Selected Research

Silvia M Vidal Research Topics

Disease

20	Infections 01/2020 - 04/2002
5	Cerebral Malaria 01/2020 - 01/2012
4	Inflammation (Inflammations) 10/2021 - 09/2013
4	Neuroinflammatory Diseases 01/2020 - 11/2016
4	Human Influenza (Influenza) 01/2014 - 05/2008
4	Virus Diseases (Viral Diseases) 04/2011 - 12/2002
3	Salmonella Infections (Salmonellosis) 01/2019 - 01/2013
2	Malaria 01/2020 - 05/2014
2	Necrosis 01/2015 - 01/2014
2	Communicable Diseases (Infectious Diseases) 09/2014 - 05/2008
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 10/2021
1	Anemia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Latent Infection 01/2018
1	Parasitic Diseases (Parasitic Disease) 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017
1	Heart Diseases (Heart Disease) 05/2014
1	Congenital Abnormalities (Deformity) 05/2014
1	Methylenetetrahydrofolate reductase deficiency 05/2014
1	Typhoid Fever (Typhoid) 01/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2013
1	Iron Overload 01/2013
1	Splenomegaly 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2012
1	Septic Shock (Toxic Shock Syndrome) 09/2010
1	Cytomegalovirus Infections (Inclusion Disease) 02/2008
1	Herpesviridae Infections (Herpesvirus Infection) 10/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2002
6	CytokinesIBA 01/2020 - 11/2008
4	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2020 - 01/2012
4	Interferon Type IIBA 01/2017 - 02/2008
3	InterferonsIBA 10/2021 - 02/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2010
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2014
2	LigandsIBA 01/2016 - 12/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015 - 02/2008
2	Virulence Factors (Pathogenicity Factors)IBA 09/2014 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2014 - 01/2012
2	Histocompatibility Antigens Class IIBA 01/2007 - 12/2002
1	Bisphosphoglycerate Mutase (Diphosphoglycerate Mutase)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	InflammasomesIBA 01/2018
1	High-Temperature Requirement A Serine Peptidase 2IBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	EnzymesIBA 01/2017
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 05/2014
1	Death Domain ReceptorsIBA 01/2014
1	Inhibitor of Apoptosis ProteinsIBA 01/2014
1	Interleukin-12 (IL 12)IBA 01/2014
1	TNF Receptor-Associated Factor 3IBA 09/2013
1	HepcidinsIBA 01/2013
1	AnkyrinsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	IronIBA 01/2013
1	Heme Oxygenase-1IBA 01/2013
1	Erythropoietin FDA Link 01/2013
1	Growth Differentiation Factor 15IBA 01/2013
1	HDL CholesterolIBA 09/2012
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 02/2012
1	Interferon-alpha (Interferon Alfa)IBA 02/2012
1	Natural Killer Cell ReceptorsIBA 04/2011
1	PerforinIBA 09/2009
1	Interleukin-10 (Interleukin 10)IBA 09/2009
1	Pharmaceutical PreparationsIBA 05/2008
1	PrionsIBA 05/2008
1	Glycoproteins (Glycoprotein)IBA 05/2006

Therapy/Procedure

1	Therapeutics 01/2018